| Literature DB >> 25799574 |
Silke Bechlars1, Claudia Jäckel1, Susanne Diescher1, Doreen A Wüstenhagen1, Stefan Kubick1, Ralf Dieckmann1, Eckhard Strauch1.
Abstract
BACKGROUND: Vibrio parahaemolyticus is a recognized human enteropathogen. Thermostable direct hemolysin (TDH) and TDH-related hemolysin (TRH) as well as the type III secretion system 2 (T3SS2) are considered as major virulence factors. As tdh positive strains are not detected in coastal waters of Germany, we focused on the characterization of trh positive strains, which were isolated from mussels, seawater and patients in Germany.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25799574 PMCID: PMC4370738 DOI: 10.1371/journal.pone.0118559
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
List of V. parahaemolyticus strains used in this study.
| Strain | Year of isolation | Sample Origin | Country | Source |
|---|---|---|---|---|
| VN-0024 | 2006 | Ring Trial | unknown | CEFAS |
| VN-0028 | 1995 | Clinical | Tanzania | BfR |
| VN-0029 | 1995 | Clinical | Germany | BfR |
| VN-0030 | 1999 | Environmental | Germany | BfR |
| VN-0038 | 2007 | Clinical | Peru | BfR |
| VN-0045 | 1988 | Clinical | USA | BfR |
| VN-0046 | 1994 | Clinical | USA | BfR |
| VN-0049 | 1991 | Clinical | Thailand | BfR |
| VN-0050 | 1994 | Clinical | Thailand | BfR |
| VN-0053 | 1999 | Environmental | Indonesia | BfR |
| VN-0055 | 1999 | Environmental | USA | BfR |
| VN-0057 | 1999 | Environmental | USA | BfR |
| VN-0058 | 1999 | Environmental | USA | BfR |
| VN-0061 | 2006 | Environmental | Spain | BfR |
| VN-0070 | 1995 | Seafood, Retail | Vietnam | BfR |
| VN-0077 | 2001 | Clinical | Norway | BfR |
| VN-0084 | 2010 | Seafood, Retail | UK | BfR |
| VN-0293 | 2011 | Primary production | Germany | LAVES |
| VN-0295 | 2012 | Seafood, Retail | Denmark | BfR |
| VN-0296 | 2012 | Seafood, Retail | Italy | BfR |
| VN-0393 | 1999 | Environmental | Germany | BfR |
| VN-0394 | 1999 | Environmental | Germany | BfR |
| VN-0395 | 1999 | Environmental | Germany | BfR |
| VN-0396 | 1950 | Seafood, Retail | Japan | BfR |
| VN-2897 | 2011 | Environmental | Germany | AWI |
| VN-3859 | 2002 | Environmental | UK | CEFAS |
| VN-3933 | 2011 | Environmental | Germany | LAGuS |
| VN-4016 | 2010 | Environmental | Netherlands | AWI |
| VN-5189 | 2011 | Environmental | Germany | IFH |
| VN-10300 | 2013 | Primary production | Germany | LAVES |
| Control strains | ||||
| VN-0022 | 2010 | Seafood, Retail | Ireland | BfR |
| ATCC43996 | 1972 | Clinical | UK | BfR |
| RIMD 2210633 | 1983 | Clinical | Japan | BfR |
1) Travel associated, isolated in Germany after return
2) Environmental German strains were from seawater.
3) Strains isolated from German mussel primary productions
4) Strains isolated in Germany from imported seafood
AWI: Alfred Wegener Institute, Helgoland, Germany;
BfR: Federal Institute for Risk Assessment, Berlin, Germany;
CEFAS: Centre for Environment, Fisheries and Aquaculture Science, Weymouth, United Kingdom;
IFH: Institute of Food Hygiene, Department of Veterinary Medicine, Freie Universität Berlin, Germany;
LAGuS: State Office for Health and Social Affairs, Rostock, Germany;
LAVES: Lower Saxony State Office for Consumer Protection and Food Safety, Cuxhaven, Germany
Polymerase chain reaction (PCR) primers, targets and amplification sizes used for genotyping.
| Target gene | Amplicon | Anneal. | |||
|---|---|---|---|---|---|
| (putative function) | Primer | Primer sequence 5’ → 3’ | size (bp) | temp. (°C) | Ref. |
|
| Trh-forward | GGCTCAAAATGGTTAAGC | 251 | 62 | [ |
| Trh-reverse | CATTTCCGCTCTCATATGC | ||||
|
| Tdh-forward | CCACTACCACTCTCATATGC | 425 | 62 | [ |
| Tdh-reverse | CCATCTGTCCCTTTTCCTGC | ||||
|
| VP1670F | ACCGATTACTCAAGGCGATG | 392 | 60 | [ |
| VP1670R | TACGTTGTTGGCGTGATTGT | ||||
|
| VPA1339F | GATTCGCGGAACTCAAGAAG | 343 | 60 | [ |
| VPA1339R | CTTGTCCGAGATCAACGTCA | ||||
|
| VPA1335F | ATGTAACGGCGGCTAGCTTA | 174 | 60 | [ |
| VPA1335R | CAAACTGTGTCAGTAGCACCA | ||||
|
| VPA1362F | CTGCAGGTATCGCATCTTCA | 250 | 60 | [ |
| VPA1362R | TTAGAACCAACCGACGAAGC | ||||
|
| VPA1327F | TGGCGAAAGAGCCATTAGAT | 97 | 60 | [ |
| VPA1327R | TCAACTCCAAATTCGCCTTC | ||||
|
| Beta_vscC2_F | GTACTTTGCTGTCTAACC | 1404 | 60 | [ |
| Beta_vscC2_R | CTTACTCTTAACTTCCGACG | ||||
|
| Beta_vscS2_F | TTGATGTTGTTTCGGCTAGC | 184 | 60 | [ |
| Beta_vscS2_R | CCACCGCCGAACTCGGCTAACAAG | ||||
|
| Beta_vopB2_F | GAGCCTGTTGCTCTATGGAGCCAGG | 942 | 60 | [ |
| Beta_vopB2_R | CGACACAGAACGCAATGCTTGCTCG | ||||
|
| Beta_vopC_F | AACCAACTTGCGACTAAATC | 594 | 60 | [ |
| Beta_vopC_R | TCCCGACAGTTTTTCTGCAC | ||||
| VPaI-1 | LVPC0387F | CTAACTCTGCCGATGCTGAC | 690 | 58 | [ |
| (genomic island) | LVPC0387R | GACCTGCCGTGCCAATAAG | |||
| VPaI-2 | LVPC0643F | AGCGTCTTGAGTTACCTAATGC | 737 | 58 | [ |
| (genomic island) | LVPC0643R | CAGTGGAATAGTGCGAATTGAAC | |||
| VPaI-3 | LVPC1083F | GGCTTCTTCGGTTAGTATGTCTC | 1010 | 68 | [ |
| (genomic island) | LVPC1083R | ATGCTGGCTTCTGATATGTTCTC | |||
| VPaI-4 | PVP2137L | CAAGCAATACAACGCAAGGAAC | 350 | 58 | [ |
| (genomic island) | PVP2137R | GGTGGCAGGTTCAACATATCTC | |||
| VPaI-5 | PVP2905F | GCCATCGCCCAGCAAATATAG | 400 | 58 | [ |
| (genomic island) | PVP2905R | CTCCACAGCCTCATCTACATTG | |||
| VPaI-6 | LVPCA1262F | GGACCTAACGGAGAACATTCATC | 661 | 58 | [ |
| (genomic island) | LVPCA1262R | CATTGGCGGAGCGAATAAGG | |||
|
| LVPCRPI11F | TCTACGGCGAAGAGGTCAAG | 837 | 54 | [ |
| LVPCRPI11R | TCAACATATCCAAGTGCTCATCC | ||||
|
| LVPC1401F | GCACGCCACTGAAGTTCTTG | 1057 | 58 | [ |
| LVPC1401R | AACGACAGATTGAGCACTTGAAG | ||||
|
| VP1390-F | TACCATCAGAGGATACAACC | 262 | 50 | [ |
| VP1390-R | AACAATGAGAACATCAAACA | ||||
|
| VP1405-F | AACCCAAGAAATATCCGCCC | 282 | 56 | [ |
| VP1405-R | TCACCCATTCAAATACCGCC | ||||
|
| VP1409-F | TGTTGCTTTCTATTGCGAC | 869 | 58 | [ |
| VP1409-R | CCATAACGACTTTTCTTTC | ||||
|
| VP0950-F | GCCAAACTTCTCAAACAACA | 298 | 50 | [ |
| VP0950-R | ATGAAACGCAATTTACCATC | ||||
|
| VP0952-F | TATGATGGTGTTTGGTGC | 276 | 50 | [ |
| VP0952-R | TGTTTTTCTGAGCGTTTC | ||||
|
| VP0962-F | GACCAAGACCCAGTGAGA | 358 | 50 | [ |
| VP0962-R | GGTAAAGCCAGCAAAGTT | ||||
|
| MTase-F | GTCTTGTCGAATAGAACTCTGA | 683 | 58 | [ |
| MTase-R | TAAGCTCCAAAATCCATACG | ||||
|
| P84-F | CATTTCCGCTCTCATATGC | 7945 | 53 | [ |
| URE6-R | ATGCTGGAATGATGTTAGGT | ||||
|
| VPA1403-F | GCCAACGAGATTCAAAACCAC | 420 | 58 | This study |
| polysaccharide | VPA1403-R | GATAGCAAGCAGGATTGGTG | |||
|
| VPA0882-F | CGTTCATTAACTCTGCTCGC | 433 | 58 | This study |
| transport protein) | VPA0882-R | CCGTTGTAAGACTGCTTTCC | |||
|
| VP2695-F | GCGTGGTTTTGATGAGAACAG | 368 | 58 | This study |
| MSHA pilin) | VP2695-R | TCAGTGTCAGAGGTTGAGTG | |||
|
| VPA1466-F | TGAACAAAAGGGCGAAACAG | 424 | 58 | This study |
| TonB system receptor) | VPA1466-R | GCTTTCCGTATCACCAGAAC | |||
|
| VPA1376-F | GACGCACAAAACGTTCAAAG | 436 | 56 | This study |
| colonization factor) | VPA1376-R | CCCCTCCATTCCAACTAAATC |
Primers used in various combinations for amplification of complete trh gene.
| Primer (forward) | Primersequence 5’ → 3’ | References |
|---|---|---|
| VPtrhx1_F | CGCATTTTTTCACCATTTCCC | This study |
| VPtrhx4_F | GGCCTCGCATTTTTTCACC | This study |
| Primer (reverse) | Primersequence 5’ → 3’ | References |
| VPtrhx1_R | TTCCCTCGAATTACGCAAC | This study |
| VPtrhx4_R | ACCTTCTGATTTAGTTCCCTCG | This study |
| IS-ele-Rev1 | GTAATGGCTAAGTCGCTGAAC | This study |
Annealing temperature was 54°C, amplicon sizes ranged from 600–700 bp.
Primers and probes used for qRT-PCR.
| Target gene | Primer/probe | Primersequence 5’ → 3’ | References |
|---|---|---|---|
| Vp-gyrB-fw | TGAAGGTTTGACTGCCGTTGT | ||
|
| Vp-gyrB-rev | TGGGTTTTCGACCAAGAACTCA | This study |
| Vp-gyrB-S2 |
| ||
| Vp-tdh-fw | TCCCTTTTCCTGCCCCC | ||
|
| Vp-tdh-rev | CGCTGCCATTGTATAGTCTTTATC | This study |
| Vp-tdh-S1 |
| ||
| VP_trh1_fw | AAAAGCGTTCACGGTCAATC | ||
|
| VP_trh1_rev | CCAGAAAGAGCAGCCATTGT | [ |
| VP_trh1_S |
| ||
| VP_trh2_fw | CCCCAGTTAAGGCAATTGTG | ||
|
| VP_trh2_rev | AGGCGCTTAACCACTTTGAA | [ |
| VP_trh2_S |
| ||
| VP_vopC_fw | AGGTGACGTCAGTGTATTGAAAGG | ||
|
| VP_vopC_rev | CACAGGTAAATGGCAACTGCTTA | This study |
| VP_vopC_S |
|
Fig 1Minimum evolution tree (ME) constructed from coding nucleotide sequences of trh gene variants.
German strains are indicated by an asterisk.
Results of genotyping of trh positive strains (see Table 1).
| Strain | ST | Hemo- | lysin | T3SS1 | T3SS2α | |
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| VN-0029 | 73 | - | 2 | + | - | - |
| VN-0030 | 73 | - | 2 | + | - | - |
| VN-0293 | 79 | - | 2 | + | - | - |
| VN-0393 | 73 | - | 2 | + | - | - |
| VN-0394 | 6 | - | 2 | + | - | - |
| VN-0395 | 73 | - | 2 | + | - | - |
| VN-2897 | 79 | - | 2 | + | - | - |
| VN-3933 | 73 | - | 2 | + | - | - |
| VN-5189 | 79 | - | 2 | + | - | - |
| VN-0053 | 967 | - | 2 | + | - | - |
| VN-0061 | 64 | - | 2 | + | - | - |
| VN-0084 | 985 | - | 2 | + | - | - |
| VN-0295 | uk | - | 2 | + | - | - |
| VN-0296 | uk | - | 2 | + | - | - |
| VN-3859 | 73 | - | 2 | + | - | - |
| VN-4016 | 987 | - | 2 | + | - | - |
| VN-0028 | 966 | - | 1 | + | - | - |
| VN-0049 | 91 | - | 1 | + | - | - |
| VN-0396 | 1 | - | 1 | + | - | - |
| VN-0024 | 50 | + | 1 | + | - | - |
| VN-0038 | 64 | + | 1 | + | - | - |
| VN-0045 | 36 | + | 1 | + | - | - |
| VN-0050 | 83 | + | 1 | + | - | - |
| VN-0046 | 34 | + | ψ | + | - | - |
| VN-0055 | 35 | + | ψ | + | - | - |
| VN-0057 | 26 | + | ψ | + | - | - |
| VN-0058 | 26 | + | ψ | + | - | - |
| VN-0077 | 34 | + | ψ | + | - | - |
| VN-0070 | 452 | - | ψ | + | - | - |
| Control | 3 | + | - | + | + | + |
* German strains are indicated by an asterisk.
**Control strain was the sequenced pandemic strain RIMD2210633 which carries two tdh genes and no trh gene.
Fig 2Minimum evolution tree (ME) constructed from the concatenated sequences of seven loci (MLST).
Sequence types (STs) of German strains (VN-No.) were compared to trh positive strains with identical or related STs of Norwegian and German strains deposited in the pubmlst database (strain-No according to database). All strains present in the database are from Norway or Germany. For some strains no information about trh sequence is available (marked as trh ). Two strains do not possess a trh gene.
Fig 3Variation of gene expression of V. parahaemolyticus strains under different growth conditions.
Bacteria were grown at 20°C in LB medium (control, dashed line) and at 37°C with the following conditions: [A] LB medium, [B] LB medium containing 0.04% crude bile and [C] LB medium containing 0.1% urea. The expression of the virulence genes trh1, trh2, vopC and tdh and housekeeping gene gyrB was determined via qRT-PCR. Using comparative CT (ΔΔCT) method for relative quantification (RQ), expression of virulence genes was normalized to the expression of gyrB. Means and standard deviations are derived from three separate experiments for each culture condition of each strain.
Fig 4Hemolytic activity of cells and supernatants on human and sheep blood.
Bacteria were cultivated in LB medium with and without 0.04% bile bovine. Cultures [A] and [C] and filtered supernatants [B] and [D] were added to a suspension of each blood type and incubated for four hours. Red blood cell lysis was determined at OD540. Control strains were VN-0022 (tdh/trh negative) and ATCC439996 (tdh positive, trh negative). All experiments were performed twice.
Hemolytic activity of TRH variants and TDH2 expressed in a cell-free system.
| Toxins | Sheep | Human | Rabbit |
|---|---|---|---|
| mTRH1 (VN-0038) | >80% | <0.01% | <0.01% |
| mTRH2–3 (VN-0029) | <0.01% | <0.01% | <0.01% |
| mTRH2–2 (VN-0293) | <0.01% | <0.01% | <0.01% |
| mTDH2 (control) | <0.01% | = 10% | = 50% |
Approx. 300 ng of soluble protein were combined with 4% erythrocyte suspension of each blood type respectively. Hemolytic activity was determined by spectro-photometrical measurement at OD570 and set in proportion (%) to the maximum hemolysis in the positive control (100%).
m = mature protein (without signal peptide)